Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity - Wikidata - wikimedia - TriplyDB

Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity

Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity

http://www.wikidata.org/entity/Q34945351

about

Honokiol, a multifunctional antiangiogenic and antitumor agent Circulating Th17, Th22, and Th1 cells are increased in psoriasis IL-17RC: a partner in IL-17 signaling and beyond Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling Cytokines as Early Markers of Colorectal Anastomotic Leakage: A Systematic Review and Meta-Analysis Profile of secukinumab in the treatment of psoriasis: current perspectives Roles of Erythroid Differentiation Regulator 1 (Erdr1) on Inflammatory Skin Diseases Cytokines in psoriasis Linker length matters, fynomer-Fc fusion with an optimized linker displaying picomolar IL-17A inhibition potency.Vitamin D analogs differentially control antimicrobial peptide/"alarmin" expression in psoriasis.Immunological and histological evaluation of clinical samples from psoriasis patients treated with anti-CD6 itolizumab Paeonol ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice by inhibiting the maturation and activation of dendritic cells Blocking TNF-alpha attenuates aneurysm formation in a murine model A systems model for immune cell interactions unravels the mechanism of inflammation in human skin.Targeting of human interleukin-12B by small hairpin RNAs in xenografted psoriatic skin.Obesity and inflammation: the linking mechanism and the complications IL-6 as a druggable target in psoriasis: focus on pustular variants.Biological products for the treatment of psoriasis: therapeutic targets, pharmacodynamics and disease-drug-drug interaction implications Serum levels of LL-37 and inflammatory cytokines in plaque and guttate psoriasis.Discovery and mechanism of ustekinumab: a human monoclonal antibody targeting interleukin-12 and interleukin-23 for treatment of immune-mediated disorders.The pro-inflammatory cytokine IL-22 up-regulates keratin 17 expression in keratinocytes via STAT3 and ERK1/2 Biologics in the management of psoriasis.Psoriasis and the risk of pneumonia: a population-based study.The antipsoriatic agent monomethylfumarate has antiproliferative, prodifferentiative, and anti-inflammatory effects on keratinocytes.Metabolic changes and serum ghrelin level in patients with psoriasis.Relationship between retinal sensitivity and disease activity in patients with psoriasis vulgaris.Psoriasis and Metabolic Syndrome--scientific evidence and therapeutic implications.Immunohistochemical expression of cathepsin L in atopic dermatitis and lichen planus.Association of cytokine gene polymorphisms with psoriasis in cases from the nile delta of egypt.IL-17 induces an expanded range of downstream genes in reconstituted human epidermis model Smoking as a permissive factor of periodontal disease in psoriasis.Serum levels of TNF-α, IL-12/23p40, and IL-17 in plaque psoriasis and their correlation with disease severity.Mean platelet volume is elevated in patients with psoriasis vulgaris.Tumor necrosis factor-alpha in patients with alopecia areata.Th1, Th2, and Th17 Cytokine Involvement in Thyroid Associated Ophthalmopathy.Histological Stratification of Thick and Thin Plaque Psoriasis Explores Molecular Phenotypes with Clinical Implications.Cross Talk between Proliferative, Angiogenic, and Cellular Mechanisms Orchestred by HIF-1α in Psoriasis.Th17 cells in human disease.Smoking and risk of incident psoriasis among women and men in the United States: a combined analysis.Evaluation of Chosen Cytokine Levels among Patients with Herpes Zoster as Ability to Provide Immune Response

P2860

Q24619765-C1ED4B66-1D1C-4A01-9715-8877FF4BE93B Q24629315-42A0C7B4-2856-4A2E-B710-7EC1024E2336 Q24629783-B6AA4164-5666-435D-ACB4-C79F2E3C785F Q24647357-E5E734CB-3B43-451E-AD9B-80EFA3652F05 Q26751235-3029FDBF-64BC-4361-8CCF-E13371FD355E Q26776303-914E9C31-A983-4BA5-95BA-B39B30A45EFA Q28074548-190BCAD1-8E13-4221-ACC8-8AB94C82BA6C Q28255491-0EC5854F-EE53-47FF-8C63-E862440AA919 Q30009438-63956349-3B94-4333-BABF-4EABC1486867 Q33485227-A26C6A75-395C-44CF-989E-C33C6EA4953F Q33573621-4BDDFE95-C98A-45B3-9A40-72DEF3A49EFC Q33598026-2647548D-33D6-4540-8D04-4E82CD260FD0 Q33637801-1B7E16B6-742B-4F33-BC3B-715D8B70EB1A Q33769731-7ACF273E-EE24-486A-9F13-1A2162CA5D21 Q33830208-C0BB0A03-9FBD-4598-A10E-3938397CE65C Q33897331-2B03DB67-E17E-409C-B923-B4FE7B8BA7A3 Q34003280-8CF8052C-1884-4225-9592-0685DAABE095 Q34099814-71BED7C9-A47F-4730-B9B9-3612CF33FD05 Q34114368-F7FD57C8-8FE5-4A31-B07D-A39967439480 Q34236439-8A8580CD-B9F5-442F-9B80-7213BE3167C3 Q34342422-DCA0E3CE-D09C-4C26-9B5E-214EC2F0D033 Q34620257-EAF2AF56-1788-413F-86D2-7045EF146075 Q34777002-0CA73AC3-0379-4340-B48E-502B751DC3C9 Q34785582-4BBFCB00-7631-4DCE-A35C-66A0DFF42601 Q34798951-1C513022-60D8-45D9-B266-62F8CB8CAA86 Q35029128-7F12D5A5-078F-463B-B587-B736843448B8 Q35045850-C3122436-BAA0-446F-B7F7-96A8013DD2A2 Q35052350-5A7719D1-FD66-41A9-9724-733C0B5A7314 Q35095402-0FD6A17D-E644-4EEB-8835-ACE75D9B1FF9 Q35108924-5158D750-A647-4D3B-894A-29948985C997 Q35126597-D45D227E-945C-450E-AE0D-61DC52BEF391 Q35155926-D6E656BC-E87E-47BD-BC2F-010711F7437E Q35421660-A032A8C1-5AF8-4903-8C2C-C41842B8099B Q35564600-50A6F89E-6347-4513-B0CF-AE53E0939073 Q35671939-9B3A585B-CEDF-43F1-8AE4-B0A75BDD6A76 Q35692116-8E7CB816-FB04-4444-9704-8C5792570017 Q35763195-986A72D3-2FD9-4A73-96B0-0887D71DEAB2 Q35820734-AE16FBB4-66A4-4CAF-8880-C2A4C8759F99 Q35896544-7237C0EF-2A2D-4869-B808-8B989AC50FFC Q35943051-106754D1-B04F-4E9F-A0EF-4BF0C8B37D84

P2860

Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity

http://www.wikidata.org/entity/Q34945351

description

2005 nî lūn-bûn

@nan

2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Serum levels of TNF-alpha, IFN ...... relation with disease severity

@ast

Serum levels of TNF-alpha, IFN ...... relation with disease severity

@en

Serum levels of TNF-alpha, IFN ...... relation with disease severity

@nl

type

label

Serum levels of TNF-alpha, IFN ...... relation with disease severity

@ast

Serum levels of TNF-alpha, IFN ...... relation with disease severity

@en

Serum levels of TNF-alpha, IFN ...... relation with disease severity

@nl

prefLabel

Serum levels of TNF-alpha, IFN ...... relation with disease severity

@ast

Serum levels of TNF-alpha, IFN ...... relation with disease severity

@en

Serum levels of TNF-alpha, IFN ...... relation with disease severity

@nl

P1433

Q34945351-C687915C-C1E1-4A37-9251-2C328ED0B8B4

P1476

Q34945351-CC930B61-6FCF-4C2D-BDC0-2DC73B624C38

P2093

Q34945351-1B2E44D5-87FE-4A5C-A795-29FB5C151838

Q34945351-54F50D72-8157-4512-9603-CCF226B8B3F7

Q34945351-693069A1-66A8-4BE4-84BD-AF4509DD2A0F

P2860

Q34945351-0C4F2447-FB4F-49C8-8221-6AF35D8D4C0D

Q34945351-1118C5B3-3A1F-4383-89FC-C50DC5A8874C

Q34945351-2CCFC8DF-3E13-4B9F-B3BE-C83DF5406678

Q34945351-3C2D6219-01D4-431E-BF30-B8E8D41EA772

Q34945351-40C410DA-5BD7-4090-97EF-9F6F3FED57EF

Q34945351-4A814857-775E-4A4A-BF8F-0E51661B46E4

Q34945351-671CF87F-4E94-4393-80D5-612EFCE72AEA

Q34945351-67FA4A83-8EF1-488F-BA5F-B77943131CF1

Q34945351-702241B3-3F97-448A-9488-5629F23AF73A

Q34945351-71432540-B0B6-4879-AC1D-8AC8FFCF226F

P304

Q34945351-58F56297-609E-4DF7-9E2A-7D26626254D3

P31

Q34945351-FF0863CC-6B00-4CAF-82E5-7809209E0CB1

P356

Q34945351-6F7A5F4F-4D50-4C9D-8DC7-B877EED14A26

P433

Q34945351-6281FFB3-3E97-4C54-BAA1-04552D31FB40

P478

Q34945351-E1E9DCCA-D97C-4E22-9386-E0CC031A57BA

P50

Q34945351-DC169084-AA07-49B0-A363-F1804CCCBED6

P577

Q34945351-6B77DB93-9652-4183-AB48-EE115B9541BA

P698

Q34945351-67A9AC5E-847F-4369-B274-1007E825F89F

P921

Q34945351-116EBE90-C8C1-49A7-B61E-8250CB7FBA01

Q34945351-E5FFE7D2-E873-470E-B67B-2B36B73E7616

P932

Q34945351-E550AE72-ED5D-41D6-9007-593435554BD1

P356

P1433

Mediators of Inflammation

P1476

Serum levels of TNF-alpha, IFN ...... relation with disease severity

@en

P2093

Murat Aral

http://www.w3.org/2001/XMLSchema#string

Ozer Arican

http://www.w3.org/2001/XMLSchema#string

Sezai Sasmaz

http://www.w3.org/2001/XMLSchema#string

P2860

2. Cytokines and chemokines.

The pathogenesis of psoriasis: immunological facts and speculations.

Cytokines in psoriasis.

Which T cells cause psoriasis?

IL-12-induced IFN-gamma is dependent on caspase-1 processing of the IL-18 precursor.

IL-6 in autoimmune disease and chronic inflammatory proliferative disease.

Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes.

Overview of psoriasis.

Analysis of cytokine expression in dermatology.

Cytokine blocking agents in dermatology.

P304

273-279

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/MI.2005.273

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

2005

http://www.w3.org/2001/XMLSchema#string

P50

Pinar Cİragİl

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16258194

http://www.w3.org/2001/XMLSchema#string

P921

P932

1533889

http://www.w3.org/2001/XMLSchema#string